Renaissance Technologies
SANA icon

Renaissance Technologies’s Sana Biotechnology SANA Stock Holding History

Renaissance Technologies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.14M Buy
1,421,500
+190,400
+15% +$663K 0.01% 1565
2026
Q2 		$4.3M Sell
1,231,100
-220,100
-15% -$709K 0.01% 1544
2026
Q1 		$4.18M Sell
1,451,200
-239,916
-14% -$945K 0.01% 1477
2025
Q4 		$6.88M Sell
1,691,116
-301,384
-15% -$1.35M 0.01% 1120
2025
Q3 		$7.07M Buy
1,992,500
+1,788,788
+878% +$6.47M 0.01% 1286
2025
Q2 		$556K Buy
+203,712
New +$420K ﹤0.01% 2782
2025
Q1 		– Sell
-319,818
Closed -$521K – 3785
2024
Q4 		$521K Buy
319,818
+303,318
+1,838% +$904K ﹤0.01% 2824
2024
Q3 		$68.6K Sell
16,500
-33,400
-67% -$175K ﹤0.01% 3313
2024
Q2 		$272K Sell
49,900
-123,000
-71% -$980K ﹤0.01% 2947
2024
Q1 		$1.73M Sell
172,900
-122,200
-41% -$915K ﹤0.01% 2128
2023
Q4 		$1.2M Buy
295,100
+100,231
+51% +$369K ﹤0.01% 2276
2023
Q3 		$754K Buy
+194,869
New +$1.05M ﹤0.01% 2487
2023
Q2 		– Sell
-61,100
Closed -$200K – 4223
2023
Q1 		$200K Sell
61,100
-104,600
-63% -$418K ﹤0.01% 3280
2022
Q4 		$655K Sell
165,700
-652,300
-80% -$3.19M ﹤0.01% 2781
2022
Q3 		$4.91M Buy
818,000
+31,200
+4% +$225K 0.01% 1456
2022
Q2 		$5.06M Sell
786,800
-53,900
-6% -$343K 0.01% 1547
2022
Q1 		$6.94M Buy
840,700
+783,400
+1,367% +$6.33M 0.01% 1368
2021
Q4 		$887K Buy
+57,300
New +$1.1M ﹤0.01% 2739
2021
Q3 		– Sell
-22,200
Closed -$436K – 3793
2021
Q2 		$436K Buy
+22,200
New +$503K ﹤0.01% 3013

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Renaissance Technologies's SANA Position: Q3 2026 in Review

Renaissance Technologies increased its Sana Biotechnology (SANA) stake by 15% in Q3 2026, buying an estimated $663K and bringing the position to 1,421,500 shares worth $4.14M. The position accounts for 0.01% of the portfolio, ranked #1565.

Renaissance Technologies first reported a position in SANA in Q2 2021 and has held it in 19 quarters since. The position peaked at $7.07M in Q3 2025. 119 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Renaissance Technologies held 1,421,500 shares of Sana Biotechnology worth $4.14M as of Q3 2026.
  • Renaissance Technologies bought 190,400 Sana Biotechnology shares in Q3 2026, an estimated $663K.
  • Sana Biotechnology made up 0.01% of Renaissance Technologies's portfolio in Q3 2026, its #1565 holding.
  • Renaissance Technologies first reported a position in Sana Biotechnology in Q2 2021 and has held it in 19 quarters since.
  • Renaissance Technologies's Sana Biotechnology position peaked at $7.07M in Q3 2025.
  • 119 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.